﻿<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article
    xmlns:mml="http://www.w3.org/1998/Math/MathML"
    xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="case-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">GJMCR</journal-id>
      <journal-title-group>
        <journal-title>Global Journal of Medical Case Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2770-8691</issn>
      <issn pub-type="ppub"></issn>
      <publisher>
        <publisher-name>Science Publications</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.31586/gjmcr.2022.483</article-id>
      <article-id pub-id-type="publisher-id">GJMCR-483</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>
          Traumatic Hyphaema: A Case Report
        </article-title>
      </title-group>
      <contrib-group>
<contrib contrib-type="author">
<name>
<surname>Soliman</surname>
<given-names>Noha</given-names>
</name>
<xref rid="af1" ref-type="aff">1</xref>
<xref rid="cr1" ref-type="corresp">*</xref>
</contrib>
      </contrib-group>
<aff id="af1"><label>1</label>National Institute for Health Research Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK</aff>
<author-notes>
<corresp id="c1">
<label>*</label>Corresponding author at: National Institute for Health Research Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK
</corresp>
</author-notes>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>10</month>
        <year>2022</year>
      </pub-date>
      <volume>2</volume>
      <issue>1</issue>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>10</month>
          <year>2022</year>
        </date>
        <date date-type="rev-recd">
          <day>28</day>
          <month>10</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>10</month>
          <year>2022</year>
        </date>
        <date date-type="pub">
          <day>28</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xa9; Copyright 2022 by authors and Trend Research Publishing Inc. </copyright-statement>
        <copyright-year>2022</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p>
        </license>
      </permissions>
      <abstract>
        Hyphaema is the presence of blood in the anterior chamber (AC) of the eye and is commonly caused by a blunt ocular trauma. In this case report, we discuss a case of a 29-years-old African man presented to the emergency department with severe right ocular pain and blurry vision following a blunt injury. This is a teaching case report aimed to discuss the management options, potential complications and visual prognosis of this particular case.
      </abstract>
      <kwd-group>
        <kwd-group><kwd>Traumatic hyphaema</kwd>
<kwd>Intraocular pressure</kwd>
<kwd>Sickle cell haemoglobinopathies</kwd>
</kwd-group>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
<title>Introduction</title><p>Traumatic hyphaema is a build-up of red blood cells (RBCs) in the anterior chamber (AC), the space between the cornea and the iris, due to blunt or penetrating trauma[
<xref ref-type="bibr" rid="R1">1</xref>], with blunt trauma being the most common cause of hyphaema of all types.[
<xref ref-type="bibr" rid="R2">2</xref>] In this case report, we discuss a case of a 29 years old African male with a medical history of sickle cell trait (SCT) who presented with right eye traumatic hyphaema.</p>
</sec><sec id="sec2">
<title>Case Report</title><p>A 29-years-old male of African origin, with a medical history of SCT, presented to A&#x26;#x00026;E complaining of pain and blurry vision in his right eye after he was hit by a squash ball. Upon presentation, unaided visual acuity (VA) was 6/12 in the right eye (OD) and 6/4 in the left eye (OS). The best corrected visual acuity (BCVA) was 6/6 OD and 6/4 OS. There was no relative afferent pupillary defect (RAPD) and Ishihara was 17/17 bilaterally. On inspection there were bruised eyelids and conjunctival injection OD. Slit lamp examination revealed clear corneas bilaterally. The AC the left eye was clear, well-formed and quiet. The right AC revealed +RBCs and a hyphaema, occupying &lt;33% of AC (Figure 1). Goldman tonometry revealed pressures of 46 mmHg OD and 16 mmHg OS. No clear view of the right fundus was observed. Fundus examination OS was normal. The patient was investigated for high IOP OD and was diagnosed with traumatic hyphaema OD. He was treated as an emergency case aiming to lower IOP medically by administrating atropinise and topical steroid with consideration of AC washout. A follow-up appointment was arranged after 2 hours.</p>
<p></p>
<fig id="fig1">
<label>Figure 1</label>
<caption>
<p>Colour photography of the right eye showing a hyphaema, which occupied less than 33% of the anterior chamber.</p>
</caption>
<graphic xlink:href="483.fig.001" />
</fig></sec><sec id="sec3">
<title>Epidemiology</title><p>The incidence of traumatic hyphaema is 12 per 100,000, with 70% happening in children.[
<xref ref-type="bibr" rid="R3">3</xref>] Most commonly it occurs in males aged 10-20 years old and often happen due to recreational or sport injuries.[
<xref ref-type="bibr" rid="R4">4</xref>] One study reported that sport injuries account for 60% of traumatic hyphaema cases.[
<xref ref-type="bibr" rid="R1">1</xref>]</p>
</sec><sec id="sec4">
<title>Pathophysiology</title><p>Traumatic hyphaema may be caused by blunt or penetrating trauma.[
<xref ref-type="bibr" rid="R2">2</xref>] Hyphaema due to blunt trauma is frequently caused by tears of the major vessels of the iris or ciliary body.[
<xref ref-type="bibr" rid="R2">2</xref>] Blunt force triggers antero-posterior compression of the closed globe, resulting in immediate equatorial expansion which generates a shearing force along the iris and ciliary body (Figure 2). [
<xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R6">6</xref>]</p>
<fig id="fig2">
<label>Figure 2</label>
<caption>
<p>The effect of blunt trauma on the eye. [5]</p>
</caption>
<graphic xlink:href="483.fig.002" />
</fig><p>Seven rings injury patterns have been described due to blunt trauma to the eye (Figure 3), including retinal dialysis, zonular dehiscence, trabecular meshwork tear, cyclodialysis, angle recession, iridodialysis and radial tears of the pupillary sphincter.[
<xref ref-type="bibr" rid="R7">7</xref>]</p>
<fig id="fig3">
<label>Figure 3</label>
<caption>
<p>The seven rings in blunt eye trauma: (1) sphincter tear, (2) iridodialysis, (3) angle recession, (4) cyclodialysis, (5) TMW tear, (6) zonular tears and (7) retinal dialysis.[7]</p>
</caption>
<graphic xlink:href="483.fig.003" />
</fig><p>Blunt ocular trauma may also cause chorioretinal injury, cataract, traumatic iritis, traumatic uveitis and commotion retinae to name a few.[
<xref ref-type="bibr" rid="R5">5</xref>] Hyphaema due to penetrating injury can also be linked with direct blood vessels injury and low IOP.[
<xref ref-type="bibr" rid="R6">6</xref>] In patients with sickle cell haemoglobinopathies, the RBCs become sickled in the aqueous humour, causing passing via trabecular meshwork (TMW) challenging,[
<xref ref-type="bibr" rid="R8">8</xref>] leading to constant IOP elevation even with small hyphaemas.[
<xref ref-type="bibr" rid="R6">6</xref>]</p>
</sec><sec id="sec5">
<title>Complications</title><p>Traumatic hyphaema can result in elevated IOP for various reasons.[
<xref ref-type="bibr" rid="R6">6</xref>] It may occur acutely due to TMW blockage due to RBCs, inflammatory cells or clot debris or because of pupillary block due to a clot affecting both AC and PC.[
<xref ref-type="bibr" rid="R6">6</xref>] In eyes with a history of traumatic hyphaema, the late-onset glaucoma incidence is 0&#x26;#x02013;20%.[
<xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R10">10</xref>] Blunt trauma with a significant IOP elevation or optic nerve contusion may lead to optic nerve damage and, in turn, permanent  worsening of vision.[
<xref ref-type="bibr" rid="R6">6</xref>] Corneal bloodstaining is another complication, with an incidence of 2-11% following traumatic hyphaema.[
<xref ref-type="bibr" rid="R6">6</xref>] Re-bleeding (secondary haemorrhage) is seen in approximately 30% of cases[
<xref ref-type="bibr" rid="R1">1</xref>] and may increase the risk of permanent visual loss.[
<xref ref-type="bibr" rid="R4">4</xref>] Other complications of traumatic hyphaema include peripheral anterior synechiae (PAS), and accommodative impairment.[
<xref ref-type="bibr" rid="R6">6</xref>] </p>
<p>Patients with sickle cell disease (SCD) or SCT, like our patient, tend to have high IOPs and respond poorly to medical treatment. They also have a higher risk of secondary haemorrhages and, even with moderate IOP rise, they are more likely to develop glaucomatous nerve damage.[
<xref ref-type="bibr" rid="R11">11</xref>] RVO has been also reported in patients with SCD/SCT as a complication of traumatic hyphaema and glaucoma.[
<xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R13">13</xref>]</p>
</sec><sec id="sec6">
<title>History and Clinical Examination</title><p>History must consist of questions related to the trauma itself including the mechanism of injury, eye pain, change in vision, photophobia, vomiting, nausea and any history of bleeding disorders especially SCT/SCD.[
<xref ref-type="bibr" rid="R4">4</xref>] Our patient was originally from Sierra Leone, a country in West Africa with a medical history of SCT.[
<xref ref-type="bibr" rid="R14">14</xref>] This case emphasises the necessity to obtain a thorough history of ethnic origin and blood disorders from all patients with hyphaemas. A thorough evaluation can be undertaken when ruptured globe[
<xref ref-type="bibr" rid="R4">4</xref>] and orbital fractures[
<xref ref-type="bibr" rid="R15">15</xref>] have been eliminated.[
<xref ref-type="bibr" rid="R4">4</xref>] Initially, the lashes, eyelids, lacrimal apparatus and cornea clarity should be inspected. Later, VA, direct and indirect pupillary responses, RAPD, confrontational visual fields and extra-ocular muscles should be evaluated.[
<xref ref-type="bibr" rid="R4">4</xref>] Ishihara chart is performed to test optic nerve function. </p>
<p></p>
<p>A full thickness laceration should be ruled out by evaluating the cornea carefully using Seidel test.[
<xref ref-type="bibr" rid="R15">15</xref>] Followed by measuring the IOP.[
<xref ref-type="bibr" rid="R4">4</xref>] Slit lamp examination on the initial visit should document corneal clarity and the cornea should be closely assessed for corneal bloodstaining. Moreover, the vertical height of the hyphaema, should be monitored closely for subsequent increase in size, which is an indication of recurrent haemorrhage.[
<xref ref-type="bibr" rid="R15">15</xref>] The AC should also be carefully evaluated to recognise the presence of, and differentiate between, RBCs, white blood cells (WBCs) and ghost cells.[
<xref ref-type="bibr" rid="R15">15</xref>] Dilated fundoscopy examination, without scleral indentation, is crucial to evaluate the posterior segment (PS) for complications related to the initial trauma.[
<xref ref-type="bibr" rid="R15">15</xref>] </p>
<p></p>
<p>Ultrasonography (B-scan) can help in viewing the PS when there is no fundus view initially, and will help to confirm the presence of vitreous haemorrhage, retinal treads, retinal detachment,[
<xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R16">16</xref>] lens dislocation and intraocular foreign bodies.[
<xref ref-type="bibr" rid="R4">4</xref>] High-frequency ultrasound biomicroscopy (UBM) may be beneficial in identifying regions of weak zonules cyclodialysis and angle recession.[
<xref ref-type="bibr" rid="R17">17</xref>] Gonioscopy can be performed six weeks following the trauma to evaluate angle recession. It must not be performed prior this time as this technique can increase the risk of re-bleeding.[
<xref ref-type="bibr" rid="R7">7</xref>] </p>
<p></p>
<p>Various grading systems are used to grade hyphaemas. They can be graded based on the amount of blood in the AC. Grade 0 (microhyphaema) occurs with suspended RBCs in the AC with no layered clot, grade I hyphaema has &lt; 33% filling of the AC, grade II has 33%-50% filling, grade III &gt;50% but &lt; total AC filling and grade IV has 100% AC filling (Figure 4[
] </p>
<p></p>
<p>Following initial investigations, a full blood count (FBC) should be requested. Furthermore, a coagulation profile should be ordered, especially for those with a known history of bleeding diathesis or who are on anticoagulants.[
<xref ref-type="bibr" rid="R4">4</xref>] Patients should be tested for sickle cell haemoglobinopathy if they have a family history of SCT or SCD or if their status is uncertain.[
<xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R5">5</xref>]</p>
<fig id="fig4">
<label>Figure 4</label>
<caption>
<p>Hyphaema grading scale.[18]</p>
</caption>
<graphic xlink:href="483.fig.004" />
</fig></sec><sec id="sec7">
<title>Differential Diagnosis (DDX)</title><p>Traumatic hyphaema due to blunt trauma. Other DDX includes spontaneous hyphaema, especially for those who have an underlying health condition such as SCD.[
<xref ref-type="bibr" rid="R4">4</xref>] Hyphaema secondary to intraocular operation or laser.[
<xref ref-type="bibr" rid="R4">4</xref>] Inflammatory or infectious conditions such as herpetic uveitis. Tumours and neovascularisation.[
<xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R6">6</xref>]</p>
<p></p>
</sec><sec id="sec8">
<title>Management</title><p>Medical management of traumatic hyphaema consists of eye protection with a protective shield, rest, elevating the head at least 30 degrees, and avoidance of aspirin, non-steroidal anti-inflammatory agents (NSAIDs) and anticoagulants.[
<xref ref-type="bibr" rid="R4">4</xref>] To enable a full examination and for pain control, topical analgesics such as topical proparacaine can be used.[
<xref ref-type="bibr" rid="R1">1</xref>] Nausea can be managed by intravenous ondansetron.[
<xref ref-type="bibr" rid="R4">4</xref>] The use of antifibrinolytic agents for example tranexamic acid for traumatic hyphaema is debatable; they have potential for lowering the rate of re-bleeding but have numerous side effects.[
<xref ref-type="bibr" rid="R1">1</xref>] Pilocarpine should be avoided in these patients as it constricts the pupil and fundus examination will be further impaired.[
<xref ref-type="bibr" rid="R6">6</xref>] </p>
<p></p>
<p>Topical cycloplegics such as cyclopentolate can be used once intraocular hypertension and acute glaucoma have been ruled out.[
<xref ref-type="bibr" rid="R4">4</xref>] They will paralyse the iris muscle and ciliary body resulting in dilatation of the pupil, consequently reducing pain and preventing the formation of posterior synechia.[
<xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R6">6</xref>] Corticosteroids will help to reduce inflammation by inhibiting fibrinolysis and stabilising the blood-ocular barrier.[
<xref ref-type="bibr" rid="R6">6</xref>] Both corticosteroids and cycloplegics can lower re-bleeding risk.[
<xref ref-type="bibr" rid="R6">6</xref>] IF IOP is &gt;25 mmHg, the first-line treatment is usually topical beta blockers and carbonic anhydrase inhibitors (CAIs).[
<xref ref-type="bibr" rid="R7">7</xref>] Examples of topical beta-blockers include beta-adrenergic antagonists (such as timolol) and topical alpha-2 agonists (such as apraclonidine).[
<xref ref-type="bibr" rid="R1">1</xref>] Examples of CAIs include topical dorzolamide, systemic methazolamide and acetazolamide.[
<xref ref-type="bibr" rid="R11">11</xref>] Oral CAIs can be used if topical CAIs are not effective in managing IOP.[
<xref ref-type="bibr" rid="R8">8</xref>] Even though oral CAIs are efficient in reducing IOP, they have various side effects.[
<xref ref-type="bibr" rid="R8">8</xref>] In case of uncontrolled IOP, intravenous mannitol can be utilised. [
<xref ref-type="bibr" rid="R8">8</xref>] In patients with sickle cell haemoglobinopathies, such as our patient, the options for medical treatment are limited. The high IOP can be managed medically by beta-adrenergic antagonists or alpha-2 adrenergic agonists.[
<xref ref-type="bibr" rid="R6">6</xref>] Topical CAIs can be added but should be used cautiously as they can reduce the aqueous pH and enhance more sickling of the RBCs.[
<xref ref-type="bibr" rid="R6">6</xref>] Methazolamide should be used if systemic CAIs is needed in patients with SCD as it leads to less systemic acidosis and, therefore, less RBCs sickling than acetazolamide.[
<xref ref-type="bibr" rid="R6">6</xref>] Mannitol can induce volume contraction and acidosis in patients with sickle cell and can be used as a last resort to avoid surgery.[
<xref ref-type="bibr" rid="R6">6</xref>] Outpatient treatment can be only considered if the patient has normal IOP, grade II or less hyphaema, no history of SCD/SCT, no coagulopathy or bleeding diathesis, and able to adhere with daily ophthalmology evaluations.[
<xref ref-type="bibr" rid="R4">4</xref>] As our patient did not meet the previous criteria, he should be admitted to hospital for careful follow up.</p>
<p></p>
<p>Surgical management (AC washing of blood with or without Trabeculectomy) of traumatic hyphaema is indicated in certain conditions when prolonged elevated IOP causes complications, for example, optic atrophy and corneal blood staining.[
<xref ref-type="bibr" rid="R4">4</xref>] To avoid corneal blood staining, AC washout is indicated if there is early corneal blood staining or the IOP &gt; 25 mmHg for five days.[
<xref ref-type="bibr" rid="R4">4</xref>] To avoid optic atrophy, AC washout is indicated if IOP &gt;60 mmHg for two days, or &gt;35 mmHg for seven days.[
<xref ref-type="bibr" rid="R4">4</xref>] To avoid PAS, AC washout is indicated for a complete hyphaema lasting for five days, or any hyphaema failing to reduce to a volume of &lt;50% by days.[
<xref ref-type="bibr" rid="R4">4</xref>] Patients with sickle cell haemoglobinopathies are at a greater risk of constant IOP elevations due to RBCs sickling and require aggressive IOP control. Surgery is indicated in SCD or SCT patients if the IOP&#x26;#x02265;24 mmHg for 24 hours or if the IOP transiently&gt;30 mmHg for two to four days.[
<xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R19">19</xref>]</p>
</sec><sec id="sec9">
<title>Prognosis</title><p>Beside the complications mentioned previously, traumatic hyphaema is typically a self-limiting condition which rarely leads to permanent vision loss if there is no associated damage to the cornea, lens or optic nerve.[
<xref ref-type="bibr" rid="R1">1</xref>] Complications and VA are worse in total hyphaema than subtotal hyphaema.[
<xref ref-type="bibr" rid="R6">6</xref>] In one study, 35% of patients achieved a VA (20/40) following total hyphaema whereas 76% of patients achieved the same VA following subtotal hyphaema.[
<xref ref-type="bibr" rid="R20">20</xref>]</p>
<p></p>
<p></p>
<p><bold>Consent:</bold> Informed consent was obtained from the patient to publish their anonymised data.</p>
<p><bold>Interest of conflict:</bold> Author declares no interest of conflict.</p>
</sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      
<ref id="R1">
<label>[1]</label>
<mixed-citation publication-type="other">Gharaibeh, A., et al., Medical interventions for traumatic hyphema. Cochrane Database of Systematic Reviews, 2019(1).
</mixed-citation>
</ref>
<ref id="R2">
<label>[2]</label>
<mixed-citation publication-type="other">Sankar, P.S., et al., Traumatic hyphema. International ophthalmology clinics, 2002. 42(3): p. 57-68.
</mixed-citation>
</ref>
<ref id="R3">
<label>[3]</label>
<mixed-citation publication-type="other">Kennedy, R.H. and R.F. Brubaker, Traumatic hyphema in a defined population. American journal of ophthalmology, 1988. 106(2): p. 123-130.
</mixed-citation>
</ref>
<ref id="R4">
<label>[4]</label>
<mixed-citation publication-type="other">Gragg, J., K. Blair, and M.B. Baker, Hyphema, in StatPearls [Internet]. 2020, StatPearls Publishing.
</mixed-citation>
</ref>
<ref id="R5">
<label>[5]</label>
<mixed-citation publication-type="other">Al-Saffar, A.A.T., A.S. Hussein, and N.M. Jamal, Traumatic hyphema frequency and management evaluation: A retrospective study. Health Science Journal, 2017. 11(1): p. 1.
</mixed-citation>
</ref>
<ref id="R6">
<label>[6]</label>
<mixed-citation publication-type="other">Walton, W., et al., Management of traumatic hyphema. Survey of ophthalmology, 2002. 47(4): p. 297-334.
</mixed-citation>
</ref>
<ref id="R7">
<label>[7]</label>
<mixed-citation publication-type="other">Milder, E. and K. Davis, Ocular Trauma and Glaucoma. International Ophthalmology Clinics, 2008. 48(4): p. 47-64.
</mixed-citation>
</ref>
<ref id="R8">
<label>[8]</label>
<mixed-citation publication-type="other">Allingham, R.R., et al., Shields textbook of glaucoma. 2012: Lippincott Williams &#x00026; Wilkins.
</mixed-citation>
</ref>
<ref id="R9">
<label>[9]</label>
<mixed-citation publication-type="other">T&#x000f6;njum, A.M., Intraocular pressure and facility of outflow late after ocular contusion. Acta Ophthalmologica, 1968. 46(5): p. 886-908.
</mixed-citation>
</ref>
<ref id="R10">
<label>[10]</label>
<mixed-citation publication-type="other">T&#x000f6;njum, A.M., Gonioscopy in traumatic hyphema. Acta Ophthalmologica, 1966. 44(4): p. 650-664.
</mixed-citation>
</ref>
<ref id="R11">
<label>[11]</label>
<mixed-citation publication-type="other">Brandt, M.T. and R.H. Haug, Traumatic hyphema: a comprehensive review. Journal of Oral and Maxillofacial Surgery, 2001. 59(12): p. 1462-1470.
</mixed-citation>
</ref>
<ref id="R12">
<label>[12]</label>
<mixed-citation publication-type="other">Jackson, H., et al., Sickle retinopathy in patients with sickle trait. Eye, 1995. 9(5): p. 589-593.
</mixed-citation>
</ref>
<ref id="R13">
<label>[13]</label>
<mixed-citation publication-type="other">Wolf, A., et al., Retinal vascular occlusion following traumatic hyphema and glaucoma, as a presenting sign of sickle cell trait. The Israel Medical Association journal: IMAJ, 2005. 7(7): p. 476-477.
</mixed-citation>
</ref>
<ref id="R14">
<label>[14]</label>
<mixed-citation publication-type="other">Roberts, G., et al., Sickle cell disease in Sierra Leone: a neglected problem. Ghana Medical Journal, 2015. 49(4): p. 258-265.
</mixed-citation>
</ref>
<ref id="R15">
<label>[15]</label>
<mixed-citation publication-type="other">Lenihan, P. and D. Hitchmoth, Traumatic Hyphema: A Teaching Case Report. Optometric Education, 2014. 39(3).
</mixed-citation>
</ref>
<ref id="R16">
<label>[16]</label>
<mixed-citation publication-type="other">Byrne, S.F., Ultrasound of the eye and orbit. 2002: Mosby Incorporated.
</mixed-citation>
</ref>
<ref id="R17">
<label>[17]</label>
<mixed-citation publication-type="other">&#x000d6;zdal, M.&#x000c7;., M. Mansour, and J. Deschenes, Ultrasound biomicroscopic evaluation of the traumatized eyes. Eye, 2003. 17(4): p. 467-472.
</mixed-citation>
</ref>
<ref id="R18">
<label>[18]</label>
<mixed-citation publication-type="other">Georgescu, R.D., et al., Hyphema-from the effect to the cause. RJMM, 2017. 120(3): p. 7.
</mixed-citation>
</ref>
<ref id="R19">
<label>[19]</label>
<mixed-citation publication-type="other">Deutsch, T.A., R.N. Weinreb, and M.F. Goldberg, Indications for surgical management of hyphema in patients with sickle cell trait. Archives of Ophthalmology, 1984. 102(4): p. 566-569.
</mixed-citation>
</ref>
<ref id="R20">
<label>[20]</label>
<mixed-citation publication-type="other">Read, J. and M.F. Goldberg, Comparison of medical treatment for traumatic hyphema, in Transactions of the American Academy of Ophthalmology and Otolaryngology. 1974.
</mixed-citation>
</ref>
    </ref-list>
  </back>
</article>